NM_052867.4:c.1733A>C
Variant summary
Our verdict is Likely pathogenic. Variant got 9 ACMG points: 9P and 0B. PM2PP2PP3_StrongPP5_Moderate
The NM_052867.4(NALCN):c.1733A>C(p.Tyr578Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_052867.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NALCN | NM_052867.4 | c.1733A>C | p.Tyr578Ser | missense_variant | Exon 14 of 44 | ENST00000251127.11 | NP_443099.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Congenital contractures of the limbs and face, hypotonia, and developmental delay Pathogenic:2
- -
- -
not provided Pathogenic:1
The Y578S variant in the NALCN gene has been reported previously as a de novo variant in anindividual with CLIFAHDD syndrome (Chong et al., 2015). The Y578S substitution was not observed inapproximately 6,500 individuals of European and African American ancestry in the NHLBI ExomeSequencing Project, indicating it is not a common benign variant in these populations. The Y578S variant isa semi-conservative amino acid substitution, which occurs at a position within the S6 pore forming domainthat is conserved across species. In vitro functional studies showed that the Y578S variant acts in adominant-negative fashion, nearly abolishing the expression of wild-type NALCN (Chong et al., 2015). Weinterpret Y578S as a pathogenic variant. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at